Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region

Reelac Eye Drops

Reelac Eye Drops

The only formula in the Jordanian market

  • Reelac E/D contains the active ingredient bromfenac sodium 0.09%, which belongs to non-steroidal anti-inflammatory drugs (NSAIDs)
  • Reelac eye drops are used to reduce eye inflammation and pain after cataract surgery in adults.
  • Reelac E/D is used for the prevention and treatment of cystoid macular edema after cataract or refractive surgeries.
  • Reelac E/D is used to reduce pain, discomfort, and inflammation after refractive surgeries.
  • Reelac E/D is used to treat cystoid macular edema associated with diabetes and ocular diseases, such as uveitis, branch vein retinal occlusion, and corneal ulcer pain.
  • Reelac E/D works to prevent the production of prostaglandins by inhibiting the enzyme cyclooxygenase-2 (COX 2), this reduces inflammation inside the eye.
  • Sterile eye drops with a pack size of 5 ml.

Dosage and method of use:

  • The recommended dose of Reelac E/D is one drop in the affected eye(s), twice daily, approximately 12 hours apart.
  • Reelac E/D is continued to be used during the first two weeks after surgery.
  • If using another drop with Reelac E/D, it is recommended to wait 5 minutes before putting in the other drop.

Share

Description

Reelac Eye Drops

The only formula in the Jordanian market

  • Reelac E/D contains the active ingredient bromfenac sodium 0.09%, which belongs to non-steroidal anti-inflammatory drugs (NSAIDs)
  • Reelac eye drops are used to reduce eye inflammation and pain after cataract surgery in adults.
  • Reelac E/D is used for the prevention and treatment of cystoid macular edema after cataract or refractive surgeries.
  • Reelac E/D is used to reduce pain, discomfort, and inflammation after refractive surgeries.
  • Reelac E/D is used to treat cystoid macular edema associated with diabetes and ocular diseases, such as uveitis, branch vein retinal occlusion, and corneal ulcer pain.
  • Reelac E/D works to prevent the production of prostaglandins by inhibiting the enzyme cyclooxygenase-2 (COX 2), this reduces inflammation inside the eye.
  • Sterile eye drops with a pack size of 5 ml.

Dosage and method of use:

  • The recommended dose of Reelac E/D is one drop in the affected eye(s), twice daily, approximately 12 hours apart.
  • Reelac E/D is continued to be used during the first two weeks after surgery.
  • If using another drop with Reelac E/D, it is recommended to wait 5 minutes before putting in the other drop.